close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

GOOG

302.24

+0.49%↑

GOOG.US

299.09

+0.14%↑

META.US

603.35

+1.68%↑

NFLX

93.49

+1.8%↑

TMUS

208.9

+0.29%↑

GOOG

302.24

+0.49%↑

GOOG.US

299.09

+0.14%↑

META.US

603.35

+1.68%↑

NFLX

93.49

+1.8%↑

TMUS

208.9

+0.29%↑

GOOG

302.24

+0.49%↑

GOOG.US

299.09

+0.14%↑

META.US

603.35

+1.68%↑

NFLX

93.49

+1.8%↑

TMUS

208.9

+0.29%↑

GOOG

302.24

+0.49%↑

GOOG.US

299.09

+0.14%↑

META.US

603.35

+1.68%↑

NFLX

93.49

+1.8%↑

TMUS

208.9

+0.29%↑

GOOG

302.24

+0.49%↑

GOOG.US

299.09

+0.14%↑

META.US

603.35

+1.68%↑

NFLX

93.49

+1.8%↑

TMUS

208.9

+0.29%↑

Strona główna・Stock List・Vivid Seats Inc (Class A)
Search

Vivid Seats Inc (Class A)

Closed

SectorCommunication services

5.6 -0.36

Neutral

Price update 23 mar 2026, 19:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

5.52

Max

5.93

Key metrics

By Trading Economics

Income

-409M

-429M

Sales

-9.6M

127M

EPS

-1.43

Profit margin

-338.024

Employees

557

EBITDA

7.4M

-1.7M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+55.67% upside

Dividends

By Dow Jones

Next Earnings

5 maj 2026

Market Stats

By TradingEconomics

Market Cap

-17M

87M

Previous open

5.96

Previous close

5.6

News Sentiment

By Acuity

50%

50%

53 / 139 Ranking in Communication services

Vivid Seats Inc (Class A) Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

DJ

Read

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

DJ

Read

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

DJ

Read

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

DJ

Read

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

DJ

Read

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

DJ

Read

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

DJ

Read

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

DJ

Read

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

DJ

Read

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

DJ

Read

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

DJ

Read

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

DJ

Read

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

DJ

Read

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

DJ

Read

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

DJ

Read

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

DJ

Read

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

DJ

Read

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

DJ

Read

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

DJ

Read

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

DJ

Read

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

DJ

Read

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

DJ

Read

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

DJ

Read

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

DJ

Read

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

DJ

Read

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

23 mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Vivid Seats Inc (Class A) Forecast

Price Target

By TipRanks

55.67% upside

12 Months Forecast

Average 8.78 USD  55.67%

High 15 USD

Low 5.65 USD

Based on 8 Wall Street analysts offering 12 month price targets forVivid Seats Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

2

Buy

5

Hold

1

Sell

Based on 8 analysts giving stock ratings to Vivid Seats Inc (Class A) - Dist in the past 3 months.

Sentiment

By Acuity

53 / 139 Ranking in Communication services

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

GOOG

Alphabet Inc. (Google, Class A)

302.24

↑ +0.49%

GOOG.US

Alphabet Inc (Class C)

299.09

↑ +0.14%

META.US

Meta Platforms Inc

603.35

↑ +1.68%

NFLX

Netflix, Inc.

93.49

↑ +1.8%

TMUS

T-Mobile US Inc

208.9

↑ +0.29%
help-icon Live chat